Clinical Trials Directory

Trials / Completed

CompletedNCT01667055

The Diagnosis of Beta-lactam Hypersensitivity in Thailand

The Optimized Diagnostic Methods for the Confirmation of Beta-lactam Hypersensitivity in Thailand

Status
Completed
Phase
Study type
Observational
Enrollment
500 (actual)
Sponsor
Chulalongkorn University · Academic / Other
Sex
All
Age
7 Years
Healthy volunteers
Not accepted

Summary

The true prevalence of drug allergy in patients with a history of beta-lactam hypersensitivity will be determined by using commercially available standard skin test reagents and the diagnostic agents available in Thailand. We hypothesize that only minority of patients with such a history are truly allergic.

Detailed description

Patients with a history of beta-lactam hypersensitivity will be evaluated by the standard skin test reagents (major and minor determinants of penicillin, amoxicillin, and clavulanic if applicable), and intravenous forms of beta-lactam antibiotics . Diagnostic values of the measurement of specific Immunoglobulin E to penicillin/aminopenicillin and skin test reagents currently available in Thailand will be comparatively analyzed with the standard skin test reagents. The measurement of drug-induced interferon-gamma releasing cells will be measured in patients with a history of non-immediate reaction.

Conditions

Timeline

Start date
2012-06-01
Primary completion
2018-12-01
Completion
2018-12-01
First posted
2012-08-17
Last updated
2019-10-29

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT01667055. Inclusion in this directory is not an endorsement.